Drory Tendler, MD
Clinical Cardiac Electrophysiology · Chandler, AZNPI 1679576177
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,440 of the $57,297 with a category attached, or 96.8%. Medtronic accounts for 79.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $24,060 and has fallen 90.1% since, to $2,384 in 2025.
Across 72 payments — averaging $795.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$46K
- Boehringer Ingelheim$11K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$158
- Novartis$141
- Stryker$73
- Boston Scientific$61
- plus $269 from 9 others
Across 131 payments — averaging $2724.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$356K
- Microport CRM USA Inc$775
What the payments were for
- Speaking & faculty fees$55,44097%
- Travel & lodging$7261%
- Food & beverage$1,1242%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $45,589 |
| Boehringer Ingelheim | 11 | $11,007 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $158 |
| Novartis | 7 | $141 |
| Stryker | 3 | $73 |
| Boston Scientific | 3 | $61 |
| Johnson & Johnson(2 entities) | 3 | $51 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $32 |
| Pfizer | 2 | $30 |
| Imperative Care, Inc | 1 | $26 |
| Abbott | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,297 in reported general payments places this provider in the 70th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
See all clinical cardiac electrophysiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 132 | $176,061 |
| XareltoRivaroxaban | 36 | $45,942 |
| Dofetilide | 183 | $35,491 |
| Flecainide Acetate | 331 | $18,220 |
| Propafenone Hcl ErPropafenone Hcl | 23 | $4,270 |
| SotalolSotalol Hcl | 94 | $2,400 |
| Amiodarone Hcl | 105 | $1,956 |
| Mexiletine Hcl | 18 | $1,707 |
| Metoprolol Succinate | 87 | $1,414 |
| Metoprolol Tartrate | 63 | $767 |
| Potassium Chloride | 22 | $420 |
| Losartan Potassium | 13 | $246 |
| Carvedilol | 30 | $216 |
| Furosemide | 42 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $176,061132 claims |
| Johnson & JohnsonXarelto | $51 | $45,94236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
Other clinical cardiac electrophysiology in Chandler
- Eric RobinsonChandler$84K
- Jaskanwal BislaChandler$70K
- Osama NiaziChandler$47K
- Viet TranChandler$47K
- Huy PhanChandler$28K
- Himal ShahChandler$18K
- Akash MakkarPhoenix$318K
- Jonathan WeissPhoenix$290K
- Ashish SadhuScottsdale$264K
- Yoaav KrauthammerPhoenix$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.